Invasive aspergillosis (IA) remains a major cause of morbidity and mortality in immunocompromised patients, with limited tools available for treatment monitoring and outcome prediction. As part of the ECMM working group on immunologic markers, a multicenter study evaluated the role …

Dear all, If you or someone you care for has knowledge or experience with Cocci Meningitis, you are invited to share your experience. The MyCARE Foundation is hosting a virtual patient-focused meeting on April 14, 2026, to ensure that patient …

We are delighted to confirm that registration is now open for FAILSAFE’s inaugural international scientific conference, Tackling the Global Threat of Fungal AMR, taking place in Bangkok, Thailand on 09–10 November 2026.   Please register here: https://cmm-failsafe.com/fungalamrconference/ This inaugural conference will convene …

Dear colleagues, On behalf of the Black Yeasts – Chaetotyriales Working Group, I am pleased to announce that the next Group meeting will take place in Barcelona on 22–23 October 2026. The workshop website is now online, and registration and …

Mucormycosis is a severe fungal infection that is challenging to diagnose as traditional methods lack sensitivity and serological testing is unavailable. As part of the ECMM Pilot Study program, the ECMM supported a multicenter study evaluating the MucorGenius® PCR assay …